Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,484 | -18,878 | -7,601 | -18,012 | -13,103 |
| Depreciation Amortization | 38 | 3 | 3 | 30 | 30 |
| Other Working Capital | 944 | 549 | 1,823 | -1,471 | 515 |
| Other Operating Activity | -4,351 | 6,272 | -3,800 | 637 | 953 |
| Operating Cash Flow | $-11,853 | $-12,054 | $-9,575 | $-18,815 | $-11,604 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 8,018 | 3,799 |
| PPE Investments | -24 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-24 | $N/A | $N/A | $8,018 | $3,799 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,897 | N/A | 18,731 | 3,123 | 13,866 |
| Other Financing Activity | -14 | 0 | 0 | -30 | -30 |
| Financing Cash Flow | $16,884 | $N/A | $18,731 | $3,094 | $13,836 |
| Exchange Rate Effect | 638 | -262 | 725 | -147 | -213 |
| Beginning Cash Position | 12,205 | 24,905 | 15,535 | 24,233 | 17,203 |
| End Cash Position | 17,850 | 12,589 | 25,415 | 16,383 | 23,021 |
| Net Cash Flow | $5,645 | $-12,316 | $9,881 | $-7,850 | $5,818 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,853 | -12,054 | -9,575 | -18,815 | -11,604 |
| Capital Expenditure | -24 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -11,877 | -12,054 | -9,575 | -18,815 | -11,604 |